- Ongoing, recruitingPhase I and Phase II (Integrated)- Other
A Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of STAR-0215 in Participants with Hereditary Angioedema (The ALPHA-STAR Trial)
This study is testing a new medicine called STAR-0215 for people with Hereditary Angioedema (HAE). We want to check if it's safe, how much your body handles, and if it helps reduce swelling attacks. It's an early-stage study to understand the medicine better.
For: Hereditary Angioedema (HAE)Czechia · Poland · Bulgaria - Active not recruitingPHASE2
A Long-term Study of STAR-0215 in Participants With Hereditary Angioedema
This study is looking into the long-term safety and effects of a treatment called STAR-0215 for people with Hereditary Angioedema (HAE). Participants will receive the treatment for up to five years, helping us understand how it works over a longer period.
For: Hereditary AngioedemaUnited States · Bulgaria · Canada